Zobrazeno 1 - 10
of 33
pro vyhledávání: '"широкая лекарственная устойчивость"'
Publikováno v:
Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, Vol 21, Iss 1, Pp 46-51 (2023)
Введение. Рифампицин-устойчивый туберкулез (РУ ТБ) – туберкулез с множественной и широкой лекарственной устойчивостью (МЛУ и ШЛУ) возбу
Externí odkaz:
https://doaj.org/article/3576100b064341b79923bf33cec1316e
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 9, Pp 21-26 (2022)
The objective: to determine the frequency of resistance of Mycobacterium tuberculosis (MTB) to the most effective anti-tuberculosis drugs in tuberculosis patients in the Republic of Karelia, to characterize cases of amplification of MTB drug resistan
Externí odkaz:
https://doaj.org/article/6074c8a6b046489ea1bbf49ae2c16c68
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 5, Pp 7-12 (2022)
The article describes a clinical case of viral pneumonia associated with COVID-19 of the only lung, it developed in the patient 30 days after pleuropneumonectomy which was done to manage fibrous cavernous pulmonary tuberculosis. The favorable course
Externí odkaz:
https://doaj.org/article/3d281b5e0d6645a991bcfd294ffc36bc
Publikováno v:
Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, Vol 20, Iss 1, Pp 29-35 (2022)
Введение. В настоящее время, несмотря на благоприятный в целом патоморфоз туберкулёза (ТБ), сохраняется ряд факторов, оказывающих негати
Externí odkaz:
https://doaj.org/article/1a5d61896771454aa4578ad4ec5d16cd
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 11, Pp 32-38 (2020)
The objective of the study: to assess the efficacy of short course chemotherapy in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis.Subjects and methods. 17 children (the median age wa
Externí odkaz:
https://doaj.org/article/84361e9990e347dc9430222394316255
Autor:
I. S. Lapshina, B. U. Salikhov, T. V. Myakisheva, S. V. Kostromtsov, A. V. Paramonov, V. A. Аndreev
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 10, Pp 28-32 (2020)
The objective: to determine factors influencing treatment efficacy in patients with multiple (MDR) and extensive (XDR) drug resistant tuberculosis. Subjects and methods. The medical files of 107 tuberculosis patients (men – 75, women – 32) were a
Externí odkaz:
https://doaj.org/article/ba0f249af49f473da9c2d01c15536bb4
Autor:
P. N. Golubchikov, D. Yu. Schegertsov, T. I. Melnikovа, D. V. Krаsnov, D. A. Skvortsov, N. G. Grischenko
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 6, Pp 52-59 (2020)
The article describes a clinical case of successful treatment of a patient with disseminated bilateral fibrous cavernous tuberculosis and extensive drug resistance, with preserved sensitivity to only one anti-tuberculosis drug; the fifth chemotherapy
Externí odkaz:
https://doaj.org/article/612b622f3fdf4bc2b94b78c4e11fdd0a
Publikováno v:
Туберкулез и болезни лёгких, Vol 97, Iss 8, Pp 38-45 (2019)
The objective of the study: to evaluate the efficacy and safety of treatment of tuberculosis patients with pre-extensive drug resistance and extensive drug resistance (XDR-TB) with regimen V using new anti-tuberculosis drugs including continuous trea
Externí odkaz:
https://doaj.org/article/dda5b9c5533d40cf942556f71abb6a5d
Publikováno v:
Туберкулез и болезни лёгких, Vol 97, Iss 7, Pp 56-60 (2019)
The article describes a clinical case demonstrating the possibility of effective and safe administration of two courses of bedaquiline within chemotherapy regimens for multiple/extensive drug resistant respiratory tuberculosis in children and adolesc
Externí odkaz:
https://doaj.org/article/c703a4dd7c8348f197a083574aa102f9
Publikováno v:
Туберкулез и болезни лёгких, Vol 97, Iss 2, Pp 20-25 (2019)
The objective of the study: to assess the efficacy of patient-oriented chemotherapy of local tuberculous lesions in children exposed to multiple/extensive drug resistant tuberculosis (MDR/XDR TB) based on the results of the immediate and postponed fo
Externí odkaz:
https://doaj.org/article/55a43d83f4b2458e8e30ed69904d1f9c